CANOQ — Cano Health Share Price
- $1.30m
- -$112.75m
- $3.14bn
- 40
- 54
- 14
- 29
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -182.12% | ||
Return on Equity | n/a | ||
Operating Margin | -47.98% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 361.38 | 831.58 | 1,609.37 | 2,738.92 | 3,137.76 | 2,859.78 | 2,873.26 | 71.66% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Cano Health, Inc. is a technology-based healthcare company delivering personalized, value-based primary care services. The Company delivers primary care that measurably improves the health, wellness, and quality of life of its patients and the communities it serves through its primary care medical centers and supporting affiliated providers. It operates primary care centers and supports affiliated medical practices in Florida, Texas, Nevada, and Puerto Rico that specialize in value-based care for seniors. It offers integrated virtual care, wellness services, ancillary services (such as physiotherapy), home services, transportation, telemedicine and 24/7 urgency line services. It provides population health management programs such as wellness activities, pharmacy services, home visits, telehealth, transition of care, and high-risk and complex care management. Its wellness services include dominoes/board games, education courses, laughter yoga, music and dancing and others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- June 3rd, 2021
- Public Since
- July 6th, 2020
- No. of Shareholders
- 96
- No. of Employees
- 2,700
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 5,409,400

- Address
- 9725 Nw 117Th Avenue, Suite 200, MIAMI, 33178
- Web
- https://canohealth.com/
- Phone
- +1 2034227700
- Auditors
- Ernst & Young LLP
Upcoming Events for CANOQ
Q2 2024 Cano Health Inc Earnings Release
Similar to CANOQ
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
ACI Global
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
FAQ
As of Today at 19:48 UTC, shares in Cano Health are trading at $0.20. This share price information is delayed by 15 minutes.
Shares in Cano Health last closed at $0.20 and the price had moved by -99.86% over the past 365 days. In terms of relative price strength the Cano Health share price has underperformed the S&P500 Index by -99.88% over the past year.
The overall consensus recommendation for Cano Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCano Health does not currently pay a dividend.
Cano Health does not currently pay a dividend.
Cano Health does not currently pay a dividend.
To buy shares in Cano Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.20, shares in Cano Health had a market capitalisation of $1.08m.
Here are the trading details for Cano Health:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CANOQ
Based on an overall assessment of its quality, value and momentum Cano Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cano Health is $0.50. That is 150% above the last closing price of $0.20.
Analysts covering Cano Health currently have a consensus Earnings Per Share (EPS) forecast of -$29.82 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cano Health. Over the past six months, its share price has underperformed the S&P500 Index by -96.73%.
As of the last closing price of $0.20, shares in Cano Health were trading -97.27% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cano Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Cano Health's directors